GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Visgeneer Inc (ROCO:4197) » Definitions » Accounts Payable & Accrued Expense

Visgeneer (ROCO:4197) Accounts Payable & Accrued Expense : NT$25.8 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Visgeneer Accounts Payable & Accrued Expense?

Visgeneer's quarterly accounts payable & accrued expense declined from Dec. 2022 (NT$23.9 Mil) to Jun. 2023 (NT$19.3 Mil) but then increased from Jun. 2023 (NT$19.3 Mil) to Dec. 2023 (NT$25.8 Mil).

Visgeneer's annual accounts payable & accrued expense declined from Dec. 2021 (NT$24.4 Mil) to Dec. 2022 (NT$23.9 Mil) but then increased from Dec. 2022 (NT$23.9 Mil) to Dec. 2023 (NT$25.8 Mil).


Visgeneer Accounts Payable & Accrued Expense Historical Data

The historical data trend for Visgeneer's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visgeneer Accounts Payable & Accrued Expense Chart

Visgeneer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.77 28.16 24.41 23.89 25.83

Visgeneer Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.41 24.14 23.89 19.31 25.83

Visgeneer Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Visgeneer (ROCO:4197) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Number 335, Sec. 6, Zhonghua Road, Xiangshan District, Hsinchu, TWN, 30094
Visgeneer Inc is a Taiwan based Biotech company involved in developing and, manufacturing biomedical products in the areas of Bacterial Fermentation, Medical Device, Cosmetics/Skin Care, and Cancer Gene identification. Its products include Blood Glucose and Ketone Monitoring System, Ginkgo Biloba series, Peptide-Complex series, Hyaluronic Acid Essence Series and High-Quality Masks among others.

Visgeneer (ROCO:4197) Headlines

No Headlines